Skip to main navigation Skip to search Skip to main content

DEFEND 2: Durable-Response Therapy Evaluation For Early- or New-Onset Type 1 Diabetes

Project: Research

Project Details

StatusFinished
Effective start/end date02/16/11 → 04/26/11

Funding

  • Tolerx Incorporated: $9,000.00